Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment
Clinical trial NCT02171325 · UNKNOWN
Trial details
- NCT number
- NCT02171325
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.